Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants
- PMID: 11826218
- DOI: 10.1542/peds.109.2.330
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants
Abstract
This statement is intended for health care professionals caring for neonates and young infants. The objectives of this statement are to review the short- and long-term effects of systemic and inhaled postnatal corticosteroids for the prevention or treatment of evolving or established chronic lung disease and to make recommendations for the use of corticosteroids in infants with very low birth weight. The routine use of systemic dexamethasone for the prevention or treatment of chronic lung disease in infants with very low birth weight is not recommended.
Comment in
-
Premature conclusions on postnatal steroid effects.Pediatrics. 2002 Jul;110(1 Pt 1):200-1; author reply 200-1. doi: 10.1542/peds.110.1.200. Pediatrics. 2002. PMID: 12093981 No abstract available.
-
Postnatal steroids to treat or prevent chronic lung disease in preterm infants.Pediatrics. 2003 Jan;111(1):221-2; author reply 221-2. doi: 10.1542/peds.111.1.221. Pediatrics. 2003. PMID: 12509584 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical